Today: 10 June 2026
Browse Category

NASDAQ:CODX 27 October 2025 - 26 May 2026

Co-Diagnostics (CODX) Stock Triples on Saudi JV Deal – Analysts See More Upside Ahead

Co-Diagnostics Stock Surges on Ebola Test Push, But One Filing Shows the Catch

Co-Diagnostics shares surged 78% to $9.03 Tuesday after the company announced progress on a PCR test for the Bundibugyo Ebola strain amid a fast-spreading outbreak in central Africa. Over 46.5 million shares traded following news of the test, which is not yet approved for sale. The company recently raised $3 million in a private placement but reported a first-quarter net loss of $9.14 million and warned of “substantial doubt” about its ability to continue.
26 May 2026
·
Co-Diagnostics Jumps; $3 Million Deal Looms

Co-Diagnostics Jumps; $3 Million Deal Looms

Co-Diagnostics announced a $3 million private placement after its stock surged 43.8% Tuesday, then fell 13.3% in after-hours trading. The company will sell 1.65 million shares or pre-funded warrants, plus warrants for up to 3.29 million more shares, nearly doubling its share count. The move follows its completion of a Bundibugyo virus assay as Ebola spreads in Congo and Uganda. Co-Diagnostics reported $8.2 million in cash at March 31.
20 May 2026
··
Co-Diagnostics Stock Surges on Ebola Assay News — The Fine Print Is Big

Co-Diagnostics Stock Surges on Ebola Assay News — The Fine Print Is Big

Co-Diagnostics shares surged 51% Tuesday after the company announced completion of an assay strategy for the Bundibugyo Ebola virus, though the test is not yet for sale and awaits regulatory approval. Trading volume topped 94 million shares. The company reported $8.23 million in cash at March 31 and a quarterly net loss of $9.14 million, raising concerns about its financial stability.
19 May 2026
···
Co-Diagnostics (CODX) Stock Triples on Saudi JV Deal – Analysts See More Upside Ahead

Co-Diagnostics (CODX) Stock Triples on Saudi JV Deal – Analysts See More Upside Ahead

Co-Diagnostics shares soared 206% to close at $1.07 on October 27 after announcing a joint venture with Arabian Eagle Manufacturing to distribute PCR tests in Saudi Arabia and 18 other countries. Over 100 million shares traded amid the surge. The stock’s market cap jumped from about $18 million to as much as $60 million. The company reported just $200,000 in Q2 revenue and recently raised $3.8 million via stock sale.
28 October 2025
··
Co-Diagnostics (CODX) Stock Skyrockets 200% on Saudi JV – Is This Just the Beginning?

Co-Diagnostics (CODX) Stock Skyrockets 200% on Saudi JV – Is This Just the Beginning?

Co-Diagnostics shares jumped over 200% to close at $1.07 on October 27 after announcing a joint venture with Arabian Eagle Manufacturing to distribute PCR tests across the Middle East and North Africa. Trading volume topped 100 million shares amid a surge in retail investor activity. The company recently reported Q2 revenue of $200,000, down sharply from the prior year. Analyst price targets ranged from $1.00 to $3.00.
27 October 2025
··

Stock Market Today

  • Sensex Ends Slightly Higher as Nifty Slips Amid Metal and PSU Bank Stock Pressure
    June 10, 2026, 1:06 PM EDT. The Indian Sensex rose modestly by 64.42 points to finish at 73,983.18, while the Nifty dropped 27.15 points to 23,214.95 on Wednesday. Selling pressure in metal, PSU bank, and real estate stocks erased intraday gains, with Hindalco Industries, Coal India, and ONGC among the top decliners. Meanwhile, select heavyweight stocks like Hindustan Unilever and Axis Bank supported the Sensex's positive close. Broader markets weakened, with the Nifty MidCap and SmallCap indices falling over 1%. Analysts noted resistance at 23,250-23,300 for Nifty and support near 23,100, cautioning that a break below may trigger further declines. Defensive sectors, including FMCG and private banking, outperformed amid a cautious trading environment marked by profit booking in cyclical stocks.

Latest articles

Cracker Barrel Jumps After Surprise Profit Forces Investors to Rethink Turnaround

Cracker Barrel Jumps After Surprise Profit Forces Investors to Rethink Turnaround

10 June 2026
Cracker Barrel shares soared 26% after a surprise Q3 profit and raised 2026 revenue and adjusted EBITDA outlook, even as restaurant traffic stayed negative; investors focused on improved guidance and cost cuts, with Wells Fargo upgrading the stock and raising its price target to $50, but risks remain if guest counts don’t recover.
Lemonade Shares Jump as Investors Zero In on Profit Path

Lemonade Shares Jump as Investors Zero In on Profit Path

10 June 2026
Lemonade shares jumped 10.6% to an intraday high above $60 after CEO Daniel Schreiber and CFO Tim Bixby appeared at Morgan Stanley’s U.S. Financials Conference, as investors focused on the company’s reiterated target for positive adjusted EBITDA in Q4 and a fresh TD Cowen price target hike, with shrinking losses and improved underwriting driving optimism.
Go toTop